Responsiveness was similar between direct and mapped SF-6D in colorectal cancer patients who declined

Journal of Clinical Epidemiology

Volumn 67, Issue 2, 2014, Pages 219-227

  Wong, Carlos K H ^a   Mulhern, Brendan ^b   Wan, Yuk Fai ^a   Lam, Cindy L K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Anchor; Colorectal cancer; Mapping; Preference based; Responsiveness; SF 6D

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CHINESE; COLORECTAL CANCER; FEMALE; FOLLOW UP; HEALTH; HEALTH STATUS; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SHORT FORM 12; SMOKING;

EID: 84891626712     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.08.011     Document Type: Article

References (58)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. K.R. Yabroff, A.B. Mariotto, E. Feuer, and M.L. Brown Projections of the costs associated with colorectal cancer care in the United States, 2000-2020 Health Econ 17 8 2008 947 959
3. National Institute for Clinical Excellence Guide to the methods of technology appraisal (reference N1618) 2008 NICE London, UK
4. J.E. Brazier, Y. Yang, A. Tsuchiya, and D.L. Rowen A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures Eur J Health Econ 11 2 2010 215 225
5. R.D. Hays, and D. Hadorn Responsiveness to change: an aspect of validity, not a separate dimension Qual Life Res 1 1992 73 75
6. G. Guyatt, S. Walter, and G. Norman Measuring change over time: assessing the usefulness of evaluative instruments J Chronic Dis 40 2 1987 171 178
7. C.L.K. Lam, J. Brazier, and S.M. McGhee Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population Value Health 11 2 2008 295 303
8. R.M. Kaplan, S. Tally, R.D. Hays, D. Feeny, T.G. Ganiats, and M. Palta et al. Five preference-based indexes in cataract and heart failure patients were not equally responsive to change J Clin Epidemiol 64 2011 497 506
9. A.S. Pickard, J.A. Johnson, and D.H. Feeny Responsiveness of generic health-related quality of life measures in stroke Qual Life Res 14 2005 207 219
10. S.A. Gerhards, M.J. Huibers, K.A. Theunissen, L.E. de Graaf, G.A. Widdershoven, and S.M. Evers The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD) Value Health 14 5 2011 732 739
11. J. Moock, and T. Kohlmann Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders Qual Life Res 17 3 2008 485 495
12. L. Buitinga, L.M.A. Braakman-Jansen, E. Taal, W. Kievit, H. Visser, and P.L.C.M. van Riel et al. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry Arthritis Care Res 64 6 2012 826 832
13. C. Gaujoux-Viala, A.C. Rat, F. Guillemin, R.M. Flipo, P. Fardellone, and P. Bourgeois et al. Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort Ann Rheum Dis 71 9 2012 1478 1483
14. M.J. Harrison, L.M. Davies, N.J. Bansback, M.J. McCoy, S.M. Verstappen, and K. Watson et al. The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis Qual Life Res 18 2009 1195 1205
15. A.S. Russell, B. Conner-Spady, A. Mintz, and W.P. Maksymowych The responsiveness of generic health status measures as assessed in patients with rheumatoid arthritis receiving infliximab J Rheumatol 30 2003 941 947
16. C.A. Marra, A.A. Rashidi, D. Guh, J.A. Kopec, M. Abrahamowicz, and J.M. Esdaile et al. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res 14 2005 1333 1344
17. C.M. McDonough, T.D. Tosteson, A.N. Tosteson, A.M. Jette, M.R. Grove, and J.N. Weinstein A longitudinal comparison of 5 preference-weighted health state classification systems in persons with intervertebral disk herniation Med Decis Making 31 2011 270 280
18. G. Barton, T. Sach, A. Avery, M. Doherty, C. Jenkinson, and K. Muir Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain Cost Eff Resour Alloc 7 1 2009 12
19. K. Stavem, S.S. Frøland, and K.B. Hellum Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS Qual Life Res 14 2005 971 980
20. C.K.H. Wong, C.L.K. Lam, W.L. Law, J.T.C. Poon, D.L.W. Kwong, and J. Tsang et al. Condition-specific measure was more responsive than generic measure in colorectal cancer: all but social domains J Clin Epidemiol 66 2013 557 565
21. L. Uwer, C. Rotonda, F. Guillemin, J. Miny, M.C. Kaminsky, and M. Mercier et al. Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer Health Qual Life Outcomes 9 2011 70
22. J.H. Best, L.P. Garrison, W. Hollingworth, S.D. Ramsey, and D.L. Veenstra Preference values associated with stage III colon cancer and adjuvant chemotherapy Qual Life Res 19 2010 391 400
23. T. Shiroiwa, T. Fukuda, and K. Tsutani Health utility scores of colorectal cancer based on societal preference in Japan Qual Life Res 18 2009 1095 1103
24. J.A. Dominitz, and D. Provenzale Patient preferences and quality of life associated with colorectal cancer screening Am J Gastroenterol 92 12 1997 2171 2178
25. D. Dobrez, D. Cella, A.S. Pickard, J.S. Lai, and A. Nickolov Estimation of patient preference-based utility weights from the functional assessment of cancer therapy - general Value Health 10 4 2007 266 272
26. R.M. Ness, A.M. Holmes, R. Klein, and R. Dittus Utility valuations for outcome states of colorectal cancer Am J Gastroenterol 94 6 1999 1650 1657
27. M.C. Hornbrook, C.S. Wendel, S.J. Coons, M. Grant, L.J. Herrinton, and M.J. Mohler et al. Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores Med Care 49 2011 321 326
28. C.K.H. Wong, C.L.K. Lam, J.T.C. Poon, and D.L.W. Kwong Clinical correlates of health preference and generic health-related quality of life in patients with colorectal neoplasms PLoS One 8 3 2013 e58341
29. D. Odom, B. Barber, L. Bennett, M. Peeters, Z. Zhao, and J. Kaye et al. Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab Int J Colorectal Dis 26 2 2011 173 181
30. L. Bennett, Z. Zhao, B. Barber, X. Zhou, M. Peeters, and J. Zhang et al. Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment Br J Cancer 105 2011 1495 1502
31. S.H. Kim, J.S. Hwang, T.W. Kim, Y.S. Hong, and M.W. Jo Validity and reliability of the EQ-5D for cancer patients in Korea Support Care Cancer 20 12 2012 3155 3160
32. N. Färkkilä, H. Sintonen, T. Saarto, H. Järvinen, J. Hänninen, and K. Taari et al. Health-related quality of life in colorectal cancer Colorectal Dis 15 5 2013 e215 e222
33. C. Hamashima Long-term quality of life of postoperative rectal cancer patients J Gastroenterol Hepatol 17 2002 571 576
34. C.K.H. Wong, C.L.K. Lam, Y.F. Wan, and D. Rowen Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer Value Health 16 2 2013 373 384
35. C.K.H. Wong, C.L.K. Lam, D. Rowen, S.M. McGhee, K.P. Ma, and W.L. Law et al. Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm Value Health 15 3 2012 495 503
36. J.E. Brazier, and J. Roberts The estimation of a preference-based measure of health from the SF-12 Med Care 42 2004 851 859
37. D.E. Beaton, S. Hogg-Johnson, and C. Bombardier Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders J Clin Epidemiol 50 1997 79 93
38. R. Jaeschke, J. Singer, and G.H. Guyatt Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials 10 1989 407 415
39. D. Osoba, G. Rodrigues, J. Myles, B. Zee, and J. Pater Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 16 1998 139 144
40. E.F. Juniper, G.H. Guyatt, A. Willan, and L.E. Griffith Determining a minimal important change in a disease-specific quality of life questionnaire J Clin Epidemiol 47 1994 81 87
41. J.G. Wright, and N.L. Young A comparison of different indices of responsiveness J Clin Epidemiol 50 1997 239 246
42. S.M. McGhee, J. Brazier, C.L.K. Lam, L.C. Wong, J. Chau, and A. Cheung et al. Quality-adjusted life years: population-specific measurement of the quality component Hong Kong Med J 17 Suppl 6 2011 17 21
43. D.Y.T. Fong, C.L.K. Lam, K.K. Mak, W.S. Lo, Y.K. Lai, and S.Y. Ho et al. The Short Form-12 Health Survey was a valid instrument in Chinese adolescents J Clin Epidemiol 63 2010 1020 1029
44. C.L.K. Lam, E.Y.Y. Tse, and B. Gandek Is the standard SF-12 Health Survey valid and equivalent for a Chinese population? Qual Life Res 14 2005 539 547
45. W.L. Ward, E.A. Hahn, F. Mo, L. Hernandez, D.S. Tulsky, and D. Cella Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument Qual Life Res 8 1999 181 195
46. C.K.H. Wong, C.L.K. Lam, W.L. Law, J.T.C. Poon, P. Chan, and D.L.W. Kwong et al. Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm J Eval Clin Pract 18 2012 1186 1195
47. C.K.H. Wong, C.L.K. Lam, B. Mulhern, W.L. Law, J.T.C. Poon, and D.L.W. Kwong et al. Measurement invariance of the Functional Assessment of Cancer Therapy-Colorectal quality-of-life instrument among modes of administration Qual Life Res 22 2013 1415 1426
48. C.B. Terwee, S.D. Bot, M.R. de Boer, D.A. van der Windt, D.L. Knol, and J. Dekker et al. Quality criteria were proposed for measurement properties of health status questionnaires J Clin Epidemiol 60 2007 34 42
49. D. Revicki, R.D. Hays, D. Cella, and J. Sloan Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes J Clin Epidemiol 61 2008 102 109
50. J.A. Husted, R.J. Cook, V.T. Farewell, and D.D. Gladman Methods for assessing responsiveness: a critical review and recommendations J Clin Epidemiol 53 2000 459 468
51. S. Walters, and J. Brazier Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D Qual Life Res 14 2005 1523 1532
52. M.H. Liang, A.H. Fossel, and M.G. Larson Comparisons of five health status instruments for orthopedic evaluation Med Care 28 1990 632 642
53. C.B. Terwee, F.W. Dekker, W.M. Wiersinga, M.F. Prummel, and P.M.M. Bossuyt On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation Qual Life Res 12 2003 349 362
54. J. Cohen Statistical power analysis for the behavioral sciences 2nd ed. 1988 Lawrence Erlbaum Associates Hillsdale, NJ
55. G.R. Norman, P. Stratford, and G. Regehr Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach J Clin Epidemiol 50 1997 869 879
56. B. Efron Better bootstrap confidence intervals J Am Stat Assoc 82 1987 171 185
57. Longworth L, Rowen D. NICE DSU Technical Support Document 10: the use of mapping methods to estimate health state utility values. 2011. [assessed on April 2013]. Available at http://www.nicedsu.org.uk/TSD%2010%20mapping%20FINAL. pdf.
58. T.D. Buskirk, and K.D. Stein Telephone vs. mail survey gives different SF-36 quality-of-life scores among cancer survivors J Clin Epidemiol 61 2008 1049 1055